mounjaro tirzepatide patent expiry us expiration Lilly's new drug Mounjaro (tirzepatide

After initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)

Several factors may influence whether a patient develops indigestion while taking tirzepatide, including baseline gastrointestinal sensitivity, dietary habits, concurrent medications, and the presence of pre-existing digestive conditions such as gastroesophageal reflux disease (GERD) or functional dyspepsia

The medication is typically administered once a week through an injection, and we will gradually adjust your dosage to ensure the best results with minimal side effects

At En Vogue IV Therapy & Wellness, we offer Tirzepatide as part of our comprehensive medical weight loss program

Side Effects May Return: Even if you had no side effects on your current medication, starting a new GLP-1 can cause initial nausea and GI symptoms